Glimepiride — brands & medicines in Pakistan
Pakistan mein Glimepiride ke 4 brands available hain. Drug class: Sulfonylurea. Neeche se koi bhi brand select karein aur uses, dosage, side effects aur price dekhein.
Quick Answer
Glimepiride is a sulfonylurea used in Pakistan for Type 2 diabetes mellitus (type 2 diabetes), Blood sugar control, Reduction of HbA1c levels (HbA1c level reduction). Available as 4 brands. Prescription required. Always confirm dose with a doctor or pharmacist.
What is Glimepiride?
Glimepiride is a sulfonylurea used in Pakistan for a range of medical conditions. Doctors and pharmacists in Pakistan recognize Glimepiride under multiple brand names — currently 4 listed on PakVita (4 tablets). The information below is a synthesis from DRAP-registered medicine entries, BNF, and WHO Essential Medicines references.
Common indications
- Type 2 diabetes mellitus (type 2 diabetes)
- Blood sugar control
- Reduction of HbA1c levels (HbA1c level reduction)
- Prevention of diabetes-related complications (diabetes related complications prevention)
- High blood pressure (BP high hona)
- Heart failure support (dil kamzor hona)
- Type 2 diabetes
- Insulin release support
Indication and dose vary by medical condition, age, weight, and other factors. Always confirm with a qualified doctor or pharmacist before starting.
Typical dosage
As prescribed
This is a general adult guidance pattern based on the manufacturer's label for one of the Glimepiride brands listed below. Children, elderly patients, pregnant women, and people with kidney or liver impairment usually need different dosing — confirm with your doctor.
Side effects
Common (usually mild)
- Hypoglycemia
- Nausea
- Vomiting
- Low blood sugar
- Weight gain
- Dizziness
Serious — stop and see a doctor
- Breathing issue
- Fainting
- Severe swelling
- Severe hypoglycaemia — confusion, loss of consciousness, seizures
Important warnings
- Don't use Amaryl Tablet if you are allergic to Glimepiride, sulfonamides, or sulfonylureas
- Avoid if you have type 1 diabetes
- Avoid if allergic to glimepiride
- Not for type 1 diabetes patients
- Do not use during diabetic ketoacidosis
- Don't use Getryl Tablet if you: Are allergic to glimepiride or sulfonamide derivatives, Have type 1 diabetes, Have diabetic ketoacidosis
Drug class
Diabetes MedicinesGlimepiride brands in Pakistan (4)
Click any brand to see full uses, dosage, side effects, prices, and warnings.
Frequently asked questions
What is Glimepiride used for in Pakistan?
Glimepiride is commonly used for Type 2 diabetes mellitus (type 2 diabetes), Blood sugar control, Reduction of HbA1c levels (HbA1c level reduction), Prevention of diabetes-related complications (diabetes related complications prevention), and other indications. It belongs to the sulfonylurea drug class.
What is the typical dosage of Glimepiride?
Typical adult dosing is described by manufacturers as: "As prescribed". Always confirm dose, duration, and timing with a qualified doctor or pharmacist — dose depends on indication, weight, age, kidney/liver function, and other medications.
What are the common side effects of Glimepiride?
Common side effects include Hypoglycemia, Nausea, Vomiting, Low blood sugar, Weight gain, Dizziness. Most are mild and resolve as the body adjusts. Stop the medicine and contact a doctor if side effects are severe, persistent, or include allergic symptoms (rash, swelling, breathing difficulty).
When should I stop Glimepiride and see a doctor?
Stop Glimepiride and seek urgent medical care if you experience: Breathing issue; Fainting; Severe swelling; Severe hypoglycaemia — confusion, loss of consciousness, seizures. These are serious signs that need immediate attention.
Is Glimepiride available without a prescription in Pakistan?
Prescription required.
What brands of Glimepiride are available in Pakistan?
4 brands of Glimepiride are listed on PakVita: 4 tablets. Browse the brand list below and click any name for prices, dosage, and full information.
Sources
- DRAP Registered Drug Products Database — Drug Regulatory Authority of Pakistan
- British National Formulary (BNF) — BMJ Group & Pharmaceutical Press
- WHO Model List of Essential Medicines, 23rd ed. — World Health Organization